These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 10381550)

  • 1. Synergistic interaction between serotonin-2 receptor and dopamine D1 receptor stimulation on striatal preprotachykinin mRNA expression in the 6-hydroxydopamine lesioned rat.
    Gresch PJ; Walker PD
    Brain Res Mol Brain Res; 1999 Jun; 70(1):125-34. PubMed ID: 10381550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serotonin 2A receptor regulation of striatal neuropeptide gene expression is selective for tachykinin, but not enkephalin neurons following dopamine depletion.
    Basura GJ; Walker PD
    Brain Res Mol Brain Res; 2001 Aug; 92(1-2):66-77. PubMed ID: 11483243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serotonin-2 receptor stimulation normalizes striatal preprotachykinin messenger RNA in an animal model of Parkinson's disease.
    Gresch PJ; Walker PD
    Neuroscience; 1999; 93(3):831-41. PubMed ID: 10473249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neonatal dopamine depletion reveals a synergistic mechanism of mRNA regulation that is mediated by dopamine(D1) and serotonin(2) receptors and is targeted to tachykinin neurons of the dorsomedial striatum.
    Campbell BM; Gresch PJ; Walker PD
    Neuroscience; 2001; 105(3):671-80. PubMed ID: 11516832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopamine receptor agonists regulate levels of the serotonin 5-HT2A receptor and its mRNA in a subpopulation of rat striatal neurons.
    Laprade N; Radja F; Reader TA; Soghomonian JJ
    J Neurosci; 1996 Jun; 16(11):3727-36. PubMed ID: 8642415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopamine D1 receptor modulation of glutamate receptor messenger RNA levels in the neocortex and neostriatum of unilaterally 6-hydroxydopamine-lesioned rats.
    Rodríguez-Puertas R; Herrera-Marschitz M; Koistinaho J; Hökfelt T
    Neuroscience; 1999 Mar; 89(3):781-97. PubMed ID: 10199613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MK-801 prevents dopamine D1 but not serotonin 2A stimulation of striatal preprotachykinin mRNA expression.
    Campbell BM; Walker PD
    Neuroreport; 2001 Apr; 12(5):953-5. PubMed ID: 11303767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Failure of MK-801 to suppress D1 receptor-mediated induction of locomotor activity and striatal preprotachykinin mRNA expression in the dopamine-depleted rat.
    Campbell BM; Kreipke CW; Walker PD
    Neuroscience; 2006; 137(2):505-17. PubMed ID: 16289829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Striatal preprotachykinin mRNA levels are regulated by stimulatory agents and dopamine D1 receptor manipulation in rodent organotypic slice cultures.
    Campbell BM; Walker PD
    Brain Res; 2001 Jan; 888(1):26-33. PubMed ID: 11146049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Locomotor-activity-induced changes in striatal levels of preprotachykinin and preproenkephalin mRNA. Regulation by the dopaminergic and glutamatergic systems.
    Liste I; Rodriguez-Pallares J; Caruncho HJ; Labandeira-Garcia JL
    Brain Res Mol Brain Res; 1999 Jun; 70(1):74-83. PubMed ID: 10381545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined intrastriatal dopamine D1 and serotonin 5-HT2 receptor stimulation reveals a mechanism for hyperlocomotion in 6-hydroxydopamine-lesioned rats.
    Bishop C; Walker PD
    Neuroscience; 2003; 121(3):649-57. PubMed ID: 14568025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain-derived neurotrophic factor enhances striatal neuropeptide expression in both the intact and the dopamine-depleted rat striatum.
    Sauer H; Campbell K; Wiegand SJ; Lindsay RM; Björklund A
    Neuroreport; 1994 Jan; 5(5):609-12. PubMed ID: 8025254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prior D1 dopamine receptor stimulation is required to prime D2-mediated striatal Fos expression in 6-hydroxydopamine-lesioned rats.
    Pollack AE; Yates TM
    Neuroscience; 1999; 94(2):505-14. PubMed ID: 10579212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential regulation of striatal preproenkephalin and preprotachykinin mRNA levels in MPTP-lesioned monkeys chronically treated with dopamine D1 or D2 receptor agonists.
    Morissette M; Grondin R; Goulet M; Bédard PJ; Di Paolo T
    J Neurochem; 1999 Feb; 72(2):682-92. PubMed ID: 9930741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MK-801 alters the effects of priming with L-DOPA on dopamine D1 receptor-induced changes in neuropeptide mRNA levels in the rat striatal output neurons.
    Van De Witte SV; Groenewegen HJ; Voorn P
    Synapse; 2002 Jan; 43(1):1-11. PubMed ID: 11746728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serotonin 5-HT2A receptors underlie increased motor behaviors induced in dopamine-depleted rats by intrastriatal 5-HT2A/2C agonism.
    Bishop C; Tessmer JL; Ullrich T; Rice KC; Walker PD
    J Pharmacol Exp Ther; 2004 Aug; 310(2):687-94. PubMed ID: 15044557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stimulation of adenosine A1 receptors attenuates dopamine D1 receptor-mediated increase of NGFI-A, c-fos and jun-B mRNA levels in the dopamine-denervated striatum and dopamine D1 receptor-mediated turning behaviour.
    Ferré S; Rimondini R; Popoli P; Reggio R; Pèzzola A; Hansson AC; Andersson A; Fuxe K
    Eur J Neurosci; 1999 Nov; 11(11):3884-92. PubMed ID: 10583477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of repeated administration of dopamine agonists on striatal neuropeptide mRNA expression in rats with a unilateral nigral 6-hydroxydopamine lesion.
    Granata R; Wenning GK; Jolkkonen J; Jenner P; Marsden CD
    J Neural Transm (Vienna); 1996; 103(3):249-60. PubMed ID: 8739837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic alterations in dopaminergic neurotransmission produce a persistent elevation of deltaFosB-like protein(s) in both the rodent and primate striatum.
    Doucet JP; Nakabeppu Y; Bedard PJ; Hope BT; Nestler EJ; Jasmin BJ; Chen JS; Iadarola MJ; St-Jean M; Wigle N; Blanchet P; Grondin R; Robertson GS
    Eur J Neurosci; 1996 Feb; 8(2):365-81. PubMed ID: 8714707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serotonin 5-HT2A but not 5-HT2C receptor antagonism reduces hyperlocomotor activity induced in dopamine-depleted rats by striatal administration of the D1 agonist SKF 82958.
    Bishop C; Daut GS; Walker PD
    Neuropharmacology; 2005 Sep; 49(3):350-8. PubMed ID: 15993442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.